PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
34816283-1	2022	PURPOSE: The purpose of this study was to compare the primary staging of F-18 labeled fibroblast activation protein inhibitor ((18F)F-FAPI) with that of F-18 labeled fluordesoxyglucose positron emission tomography/computed tomography ((18F)F-FDG PET/CT) in patients with lung adenocarcinoma (LAD).	fluordesoxyglucose	166-184	mastermind like domain containing 1	Homo sapiens	153-157
17173784-0	2006	[Positron emission tomography with fluordesoxyglucose-F18 in follow-up of endometrial cancer].	fluordesoxyglucose	35-53	mastermind like domain containing 1	Homo sapiens	54-57